Mayo Clinic to sequence genome for thousands in personalized medicine embrace

The Mayo Clinic will sequence the genome for thousands of patients in a major pilot study slated to begin early in 2012 as part of a significant move toward "proactive genomics" and personalized medicine, The Guardian reports. Plans call for linking patients' genetic code to their medical records. Doctors can then tap into this information to prescribe the most effective treatment for each individual person with the least amount of side effects. The plunging price tag for genetic tests has, in part, made the pilot study possible, clinic officials said. Story

Suggested Articles

Researchers have demonstrated that targeting a potassium ion channel called Kv2.1 can protect the brain from neuronal damage after a stroke.

Antivirals from Roche, Bristol Myers Squibb, Viiv and Gilead, or modified versions of them, could prove effective against COVID-19, researchers said.

Stanford's insulin formulation reached peak activity in pig models of diabetes about twice as fast as commercially available options.